Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection.
about
CD8 T cell persistence in treated HIV infectionExpansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis InfectionEarly skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progressionProgrammed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.Subsets of memory CD4+ T cell and bactericidal antibody response to Neisseria meningitidis serogroup C after immunization of HIV-infected children and adolescents.Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individualsEffects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients.Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cellsLipopolysaccharide Increases Immune Activation and Alters T Cell Homeostasis in SHIVB'WHU Chronically Infected Chinese Rhesus Macaque.Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.Immune Suppression by Myeloid Cells in HIV Infection: New Targets for ImmunotherapyConserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.Increased Immune Activation and Exhaustion in HIV-infected Youth.Immune checkpoints and the HIV-1 reservoir: proceed with caution.Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses.Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infection.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection
P2860
Q27014768-73BD06AA-3A1C-49A5-8686-E8E3E0A1A33FQ33650173-E0A70B62-DAF2-4D16-9B20-94D66A497C6DQ34004816-32279972-13A9-42BF-89AC-608F70BE50C6Q34388154-2F5C44EB-AEC7-4E6A-9F90-947891F7631DQ34757967-DD559E5D-FAB7-4418-BFBC-4B97E490667EQ35043697-B0F19D27-018F-402C-9A9B-E557CA4289E8Q35115728-3B356C6B-9E61-4196-8304-B812E0A50118Q35856740-42921D97-6558-42AB-8F05-3D9FA67A6739Q35965172-986DEA39-6B07-4F3D-8CC1-0C976271FE4DQ36181681-4C5931DF-C02C-4F56-8207-3B51DC4E6EFAQ36316589-7420A524-22A1-4C5D-9092-9BB5559A0C4BQ36374620-1D341C68-2475-4865-9CD6-4EE12147FE3AQ36678143-311FCFFD-C7FF-4840-93F8-005288F9CB27Q39048479-71D0088E-4B55-4D82-A7A3-1FE214EC7AD3Q39147410-FC421B9E-4A9A-4E93-A8D2-F5B75CB253ADQ40053061-2B845FF9-98C3-41F1-B521-0286A415EA25Q40094624-605C1777-7408-482D-92AB-13623A0EB00BQ40536799-5275DBC5-9DA7-47DE-AABF-BB0A1D8AFCD9Q40540735-25124FE3-D4D5-4577-B3C3-D432126B54F7Q40591659-10F639FC-5B71-4D32-A105-375832C24103Q40615883-08545890-3459-4650-881B-962C0748163EQ40865499-6BAB9553-82D2-41B5-A5F6-707095638C7FQ42207149-59B32D31-4292-4756-8C63-08156B47308FQ53755427-A75FE028-1E69-4D0A-BEE9-772C28D8C67BQ54259809-8242B71A-54B4-438B-A1D2-57291E2F1D7BQ58572549-4F24A687-7F2C-4D53-8DFF-36E48D02D6C0
P2860
Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@en
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@nl
type
label
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@en
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@nl
prefLabel
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@en
Programmed death-1 is a marker ...... ll subsets in HIV-1 infection.
@nl
P2093
P2860
P356
P1476
Programmed death-1 is a marker ...... ell subsets in HIV-1 infection
@en
P2093
Abdelali Filali-Mouhim
Bader Yassine-Diab
Catherine Riou
Gaëlle Breton
Jean-Pierre Routy
Jeffrey Ahlers
Mohamed-Rachid Boulassel
Rafick-Pierre Sékaly
Rémi Fromentin
P2860
P304
P356
10.4049/JIMMUNOL.1200646
P407
P577
2013-08-05T00:00:00Z